Tacrolimus Capsule
NDC Package 72189-536-30
Package Information
Tacrolimus capsules is 1.1 Prophylaxis of Organ Rejection in Kidney, Liver, or Heart TransplantTacrolimus capsules are indicated for the prophylaxis of organ rejection, in adult patients receiving allogeneic kidney transplant [see Clinical Studies (14.1)], liver transplant [see Clinical Studies (14.2)], and heart transplant [see Clinical Studies (14.3)], and pediatric patients receiving allogeneic liver transplants [see Clinical Studies (14.2)] in combination with other immunosuppressants.Additional pediatric use information is approved for Astellas Pharma US, Inc.’s Prograf (tacrolimus) products. This formulation utilizes a capsule delivery system. Marketed by Direct_rx, this product is identified by NDC 72189-536 and is authorized under FDA application ANDA065461.
Identification & Billing
- RxCUI: 198377 - tacrolimus 1 MG Oral Capsule
- RxCUI: 198377 - tacrolimus 1 MG (as anhydrous tacrolimus) Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72189 - Direct_rx
- 72189-536 - Tacrolimus
- 72189-536-30 - 30 CAPSULE in 1 BOTTLE
- 72189-536 - Tacrolimus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72189-536-30 identifies a specific commercial package of 30 capsule in 1 bottle of Tacrolimus, a human prescription drug labeled by Direct_rx. This capsule is formulated for oral use and contains tacrolimus as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Direct_rx on February 07, 2024. The current certification is valid through December 31, 2026.
How is this Direct_rx product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72189053630. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.